Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulseâ„¢ technology using its proprietary Nanosecond Pulsed Field Ablationâ„¢ (nanosecond PFA or nsPFAâ„¢) energy, today announced the ...
Paul LaViolette to serve as Co-Chairman alongside Robert W. Duggan, adding 40 years of medical technology development, operating and leadership expertise MIAMI--(BUSINESS WIRE)--Pulse Biosciences, Inc ...